| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/21/2013 | US8445237 RNA interference mediating small RNA molecules |
| 05/21/2013 | US8445234 Methods of making VEGF-D polypeptides |
| 05/21/2013 | US8445233 PGC-1β, a novel PGC-1 homologue and uses therefor |
| 05/21/2013 | US8445017 Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof |
| 05/21/2013 | US8444964 Compositions and methods for enhanced tumor cell immunity in vivo |
| 05/21/2013 | CA2522614C Vaccine accelerator factor (vaf) for improvement of vaccinations in poultry |
| 05/21/2013 | CA2454147C Inhibitor of dna methylation |
| 05/21/2013 | CA2436666C Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 05/21/2013 | CA2412436C Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 05/16/2013 | WO2013071030A1 Provasopressin antagonists and uses thereof |
| 05/16/2013 | WO2013070952A1 Transcription factor-based generation of pacemaker cells and methods of using same |
| 05/16/2013 | WO2013070763A1 Aptamer-loaded, biocompatible nanoconstructs for nuclear-targeted cancer therapy |
| 05/16/2013 | WO2013070324A1 Edible plant-derived microvesicle compositions for diagnosis and treatment of disease |
| 05/16/2013 | WO2013069611A1 Rna having immunomodulating activity |
| 05/16/2013 | WO2013068413A1 Rod cell-specific promoter |
| 05/16/2013 | WO2013067873A1 Anti-influenza virus nucleic acid, peptide nucleic acid and formulation thereof |
| 05/16/2013 | WO2013044044A3 Methods of treating fatty liver disease with helminth-derived glycan-containing compounds |
| 05/16/2013 | WO2013040504A3 Srpx for treatment of cancer |
| 05/16/2013 | US20130125259 Rna interference mediating small rna molecules |
| 05/16/2013 | US20130123750 Methods, compositions and apparatus for delivering heterologous molecules to cells |
| 05/16/2013 | US20130123346 Synthetic constructs for polynucleotide & protein expression |
| 05/16/2013 | US20130123340 Compositions and methods for the treatment and prevention of cardiac ischemic injury |
| 05/16/2013 | US20130123338 Novel cationic lipids and methods of use thereof |
| 05/16/2013 | US20130123336 Polyplexes of Hydrophobically-Modified siRNA for Delivery of siRNA |
| 05/16/2013 | US20130123332 Compositions and methods for inhibiting expression of mylip/idol gene |
| 05/16/2013 | US20130123329 Microrna compositions and methods |
| 05/16/2013 | US20130123327 Combined use of prame inhibitors and hdac inhibitors |
| 05/16/2013 | US20130122585 Synthetic gagpol genes and their uses |
| 05/16/2013 | US20130122105 Methods and Compositions for Gene Therapy and GHRH Therapy |
| 05/16/2013 | US20130122083 Dna vaccines encoding heat shock proteins |
| 05/16/2013 | US20130122082 Methods And Compositions For The Treatment And Prevention Of Aging-Associated Conditions |
| 05/16/2013 | US20130121995 Compositions and Methods for Increasing Bone Mineralization |
| 05/16/2013 | CA2854563A1 Provasopressin antagonists and uses thereof |
| 05/15/2013 | EP2591792A1 Composition for nucleic acid delivery, carrier composition, pharmaceutical composition using the composition for nucleic acid delivery or the carrier composition, and method for delivering nucleic acid |
| 05/15/2013 | EP2590665A1 Adenovirus ad36 e4orf1 protein for prevention and treatment of non-alcoholic fatty liver disease |
| 05/15/2013 | CN103108650A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases |
| 05/15/2013 | CN103103264A Application of SMOC2 gene in preparation of medicine for detecting or treating endometrial cancer and ovarian cancer |
| 05/15/2013 | CN103103195A Sequence of aptamer for outer membrane protein TolC of escherichia coli and application of sequence |
| 05/15/2013 | CN103103192A RNA (Ribonucleic Acid) interference fragment of targeted vascular angiotensin peptide and expression vector, hybrid clone cell strain and application thereof |
| 05/15/2013 | CN103100093A Load small interfering RNA nanoscale lipid microbubble ultrasonic contrast agent and preparation method |
| 05/15/2013 | CN103100092A Application of human cytokine CCDC134 |
| 05/15/2013 | CN102643822B Heartworm nucleic acid vaccine and method for preparing same |
| 05/15/2013 | CN102399777B Recombinant plasmid and recombinant oncolytic virus prepared by using the same |
| 05/15/2013 | CN102140467B Human miR-365 antisense nucleic acid and application thereof |
| 05/15/2013 | CN101988057B Promoter and application thereof |
| 05/15/2013 | CN101920020B New application of human MED19 genes in tumor therapy |
| 05/15/2013 | CN101287831B T-cell receptor and nucleic acid encoding the receptor |
| 05/15/2013 | CN101160138B RNAi抑制CTGF用于治疗眼科疾病 RNAi inhibition of CTGF for the treatment of ophthalmic diseases |
| 05/14/2013 | US8440801 Aptamer against IL-17 and use thereof |
| 05/14/2013 | US8440788 N-terminal VDAC variants and uses thereof |
| 05/14/2013 | US8440637 Combination treatment for the treatment of hepatitis C virus infection |
| 05/14/2013 | US8440636 Micro-RNA family that modulates fibrosis and uses thereof |
| 05/14/2013 | US8440630 Akt activity specifically inhibiting polypeptide |
| 05/14/2013 | US8440205 Streptococcal C5A peptidase vaccine |
| 05/14/2013 | US8440202 Induction of an immune response against dengue virus using the prime-boost approach |
| 05/14/2013 | CA2548202C Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 05/14/2013 | CA2533708C Transposon-based vectors and methods of nucleic acid integration |
| 05/14/2013 | CA2521217C Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| 05/14/2013 | CA2455915C Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 05/14/2013 | CA2388298C The use of csf-1 inhibitors |
| 05/14/2013 | CA2263890C Recombinant vascular endothelial cell growth factor d (vegf-d) |
| 05/10/2013 | WO2013067531A2 Methods of using microrna 195 in providing neuroprotection |
| 05/10/2013 | WO2013067125A1 Co-activation of mtor and stat3 pathways to promote neuronal survival and regeneration |
| 05/10/2013 | WO2013066721A2 Methods and compositions for the specific inhibition of met by double-stranded rna |
| 05/10/2013 | WO2013066485A2 Compositions and methods for treatment of metastatic cancer |
| 05/10/2013 | WO2013066442A2 Mammalian genes and gene products involved in infection |
| 05/10/2013 | WO2013066368A1 Use of mirna 126 to produce hematopoietic stem cells |
| 05/10/2013 | WO2013065913A1 Gene therapy for diabetic neuropathy using an hgf isoform |
| 05/10/2013 | WO2013065791A1 Double-stranded nucleic acid molecule for gene expression control |
| 05/10/2013 | WO2013065690A1 Prophylactic or therapeutic agent for virus infectious disease |
| 05/10/2013 | WO2013064844A2 Method for de-differentiating a cell |
| 05/10/2013 | WO2013036827A3 Fungal-specific metalloproteases and uses thereof |
| 05/10/2013 | WO2013036465A3 A conditional replicating cytomegalovirus as a vaccine for cmv |
| 05/10/2013 | WO2013032231A3 Pharmaceutical anti-angiogenic composition including a microrna-382 inhibitor |
| 05/10/2013 | WO2013032230A3 Pharmaceutical angiogenic composition including a microrna-382 activator |
| 05/10/2013 | WO2012178022A3 Therapeutic applications targeting sarm1 |
| 05/10/2013 | WO2012174543A3 Phosphonium-containing polyelectrolytes for nonviral gene delivery |
| 05/10/2013 | CA2854225A1 Co-activation of mtor and stat3 pathways to promote neuronal survival and regeneration |
| 05/10/2013 | CA2853918A1 Gene therapy for diabetic neuropathy using an hgf isoform |
| 05/10/2013 | CA2846074A1 Compositions and methods for treatment of metastatic cancer |
| 05/09/2013 | US20130116311 Catecholamine enzyme fusions |
| 05/09/2013 | US20130116309 Oligomeric compounds for the modulation of hif-1a expression |
| 05/09/2013 | US20130116307 Novel cyclic cationic lipids and methods of use |
| 05/09/2013 | US20130116305 Methods and compositions for the inhibition of hiv-1 replication |
| 05/09/2013 | US20130116299 Methods and compositions for increasing sensitivity to tyrosine kinase inhibitors |
| 05/09/2013 | US20130115696 siRNA that Inhibits WT1 Gene Expression and Uses Thereof |
| 05/09/2013 | US20130115692 Methods and compositions relating to improved lentiviral vectors and their applications |
| 05/09/2013 | US20130115658 Reversible, parallel and multitask cloning method and kit |
| 05/09/2013 | US20130115239 Prostate cancer dna vaccine |
| 05/09/2013 | US20130115221 HIFa prolyl hydroxylation assay |
| 05/08/2013 | EP2589654A1 CD40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity |
| 05/08/2013 | EP2588143A2 Novel agonists of toll-like receptor 3 and methods of their use |
| 05/08/2013 | EP2588082A2 Compositions and methods for enhancement of nucleic acid delivery |
| 05/08/2013 | CN103097535A Method for producing novel hipsc by means of sirna introduction |
| 05/08/2013 | CN103096934A Non-aqueous high concentration reduced viscosity suspension formulations |
| 05/08/2013 | CN103096899A Inhibitor of hmgb protein-mediated immune response activation, and screening method |
| 05/08/2013 | CN103096875A Biodegradable lipids for the delivery of active agents |
| 05/08/2013 | CN103088064A Liver cancer tissue specific RNA (Ribose Nucleic Acid) interference system, as well as construction method and application method thereof |
| 05/08/2013 | CN103088063A Recombinant pseudotype baculovirus expressing rabies virus G protein and application |
| 05/08/2013 | CN103088061A Application of RNA and carrier in preparation of product for preventing and/or treating liver cancer |